Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston

Aureka Biotechnologies at Discovery on Target 2026

Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website

Aureka Biotechnologies brings 3 presentations to Discovery on Target 2026 in Boston. Its program centres on AI-designed antibodies that modulate GPCRs and on how AI is changing target discovery, design and modulation for functional biologics.

OrganizationDiscovery on Target 2026 Attendance
Biotech
AI-driven start-up discovering antibody therapeutics, including GPCR modulators, for cardiometabolic and inflammatory diseases.
Chair
Tue Sep 29
1:45pm–1:50pm
Chairperson’s Remarks
Antibodies Against Challenging Targets
Talk
Tue Sep 29
2:20pm–2:50pm
Engineering Function: AI-Designed Antibodies that Modulate GPCRs
Antibodies Against Challenging Targets
Panel
Wed Sep 30
7:30am–8:15am

Explore the full Discovery on Target 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full Discovery on Target 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Aureka Biotechnologies

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction